Patrick Trucchio
Stock Analyst at H.C. Wainwright
(4.84)
# 399
Out of 4,399 analysts
1151
Total ratings
48.4%
Success rate
20.9%
Average return
Main Sectors:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGMO Sangamo Therapeutics, Inc. | Rated: Hold | n/a | $0.149 | - | 51 | Jun 9, 2026 | |
| VYGR Voyager Therapeutics | Reiterated: Buy | $25 | $3.32 | +653.01% | 24 | Jun 8, 2026 | |
| CSE: DRUG Bright Minds Biosciences Inc. | Reiterated: Buy | $202.22 | $87.26 | +131.75% | 13 | Jun 8, 2026 | |
| ATAI AtaiBeckley | Reiterated: Buy | $25 | $3.78 | +561.38% | 53 | Jun 8, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $510 | $291.22 | +75.13% | 72 | Jun 5, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $100 | $70.73 | +41.38% | 66 | Jun 3, 2026 | |
| ALT Altimmune | Maintained: Buy | $20 | $2.61 | +666.28% | 48 | Jun 3, 2026 | |
| ASMB Assembly Biosciences | Reiterated: Buy | $50 | $22.26 | +124.62% | 14 | Jun 3, 2026 | |
| DTIL Precision BioSciences | Reiterated: Buy | $60 | $6.45 | +830.23% | 64 | Jun 3, 2026 | |
| VIR Vir Biotechnology | Reiterated: Buy | $20 | $8.25 | +142.42% | 66 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $5.16 | +868.99% | 19 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $27.90 | +258.42% | 52 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.156 | +3,105.13% | 48 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.8001 | +1,149.84% | 49 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $3.76 | +1,096.81% | 10 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $19.68 | +154.07% | 17 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $6.02 | +1,146.88% | 41 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $35.48 | +55.02% | 23 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $11.03 | +534.63% | 57 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $29.49 | +171.28% | 26 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.43 | +599.30% | 6 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $65 | $20.36 | +219.25% | 39 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.9009 | +1,010.00% | 36 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $31.51 | +90.42% | 8 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $23.24 | +201.20% | 43 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $50 | $26.82 | +86.43% | 59 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 1,000p | $43.99 | +2,173.24% | 24 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $3.87 | +2,354.78% | 42 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $10 | $1.22 | n/a | 34 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $360 | $12.87 | n/a | 14 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.39 | n/a | 5 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.055 | n/a | 5 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 100p → 46p | $8.40 | n/a | 3 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €33.00 | $4.59 | n/a | 10 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $66 → $24 | $45.09 | n/a | 2 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $130 | $11.75 | n/a | 3 | Sep 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $117 → $72 | $11.17 | n/a | 2 | Nov 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $3.35 | n/a | 1 | Apr 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $23.00 | n/a | 1 | Apr 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $125 | $101.58 | n/a | 1 | Dec 23, 2014 |
Sangamo Therapeutics, Inc.
Jun 9, 2026
Rated: Hold
Price Target: n/a
Current: $0.149
Upside: -
Voyager Therapeutics
Jun 8, 2026
Reiterated: Buy
Price Target: $25
Current: $3.32
Upside: +653.01%
Bright Minds Biosciences Inc.
Jun 8, 2026
Reiterated: Buy
Price Target: $202.22
Current: $87.26
Upside: +131.75%
AtaiBeckley
Jun 8, 2026
Reiterated: Buy
Price Target: $25
Current: $3.78
Upside: +561.38%
Alnylam Pharmaceuticals
Jun 5, 2026
Reiterated: Buy
Price Target: $510
Current: $291.22
Upside: +75.13%
Arrowhead Pharmaceuticals
Jun 3, 2026
Reiterated: Buy
Price Target: $100
Current: $70.73
Upside: +41.38%
Altimmune
Jun 3, 2026
Maintained: Buy
Price Target: $20
Current: $2.61
Upside: +666.28%
Assembly Biosciences
Jun 3, 2026
Reiterated: Buy
Price Target: $50
Current: $22.26
Upside: +124.62%
Precision BioSciences
Jun 3, 2026
Reiterated: Buy
Price Target: $60
Current: $6.45
Upside: +830.23%
Vir Biotechnology
Jun 3, 2026
Reiterated: Buy
Price Target: $20
Current: $8.25
Upside: +142.42%
Jun 3, 2026
Reiterated: Buy
Price Target: $50
Current: $5.16
Upside: +868.99%
Jun 3, 2026
Reiterated: Buy
Price Target: $100
Current: $27.90
Upside: +258.42%
Jun 2, 2026
Reiterated: Buy
Price Target: $5
Current: $0.156
Upside: +3,105.13%
May 29, 2026
Reiterated: Buy
Price Target: $10
Current: $0.8001
Upside: +1,149.84%
May 28, 2026
Reiterated: Buy
Price Target: $45
Current: $3.76
Upside: +1,096.81%
May 27, 2026
Reiterated: Buy
Price Target: $50
Current: $19.68
Upside: +154.07%
May 26, 2026
Maintained: Buy
Price Target: $75
Current: $6.02
Upside: +1,146.88%
May 22, 2026
Reiterated: Buy
Price Target: $55
Current: $35.48
Upside: +55.02%
May 22, 2026
Reiterated: Buy
Price Target: $70
Current: $11.03
Upside: +534.63%
May 21, 2026
Reiterated: Buy
Price Target: $80
Current: $29.49
Upside: +171.28%
May 19, 2026
Reiterated: Buy
Price Target: $10
Current: $1.43
Upside: +599.30%
May 19, 2026
Reiterated: Buy
Price Target: $70 → $65
Current: $20.36
Upside: +219.25%
May 19, 2026
Reiterated: Buy
Price Target: $10
Current: $0.9009
Upside: +1,010.00%
May 15, 2026
Reiterated: Buy
Price Target: $60
Current: $31.51
Upside: +90.42%
May 13, 2026
Reiterated: Buy
Price Target: $70
Current: $23.24
Upside: +201.20%
May 6, 2026
Reiterated: Buy
Price Target: $70 → $50
Current: $26.82
Upside: +86.43%
May 4, 2026
Reiterated: Buy
Price Target: 1,000p
Current: $43.99
Upside: +2,173.24%
Apr 28, 2026
Reiterated: Buy
Price Target: $95
Current: $3.87
Upside: +2,354.78%
Apr 2, 2025
Maintained: Buy
Price Target: $25 → $10
Current: $1.22
Upside: n/a
May 15, 2023
Maintained: Buy
Price Target: $20 → $360
Current: $12.87
Upside: n/a
Feb 10, 2023
Rated: Hold
Price Target: n/a
Current: $10.39
Upside: n/a
Feb 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.055
Upside: n/a
Nov 2, 2022
Reiterated: Buy
Price Target: 100p → 46p
Current: $8.40
Upside: n/a
Mar 27, 2020
Maintained: Buy
Price Target: €33.00
Current: $4.59
Upside: n/a
Nov 8, 2019
Downgraded: Hold
Price Target: $66 → $24
Current: $45.09
Upside: n/a
Sep 18, 2019
Maintained: Buy
Price Target: $120 → $130
Current: $11.75
Upside: n/a
Nov 13, 2018
Downgraded: Hold
Price Target: $117 → $72
Current: $11.17
Upside: n/a
Apr 19, 2018
Initiated Coverage: Buy
Price Target: $25
Current: $3.35
Upside: n/a
Apr 19, 2018
Initiated Coverage: Buy
Price Target: $22
Current: $23.00
Upside: n/a
Dec 23, 2014
Upgraded: Buy
Price Target: $125
Current: $101.58
Upside: n/a